NCT06129201

Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging

Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging: a Prospective Multicenter Cross-sectional Study
Fifth Affiliated Hospital, Sun Yat-Sen University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Nasopharyngeal Carcinoma
Drug/Device/Intervention
Tongue image
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Fifth Affiliated Hospital, Sun Yat-Sen University
Location
Zhuhai, China
Timeline & enrollment
Phase
N/A
Start date
Nov 15, 2023
End date
Dec 01, 2025
Enrollment
5000 participants
Primary outcome

Area Under Curve (AUC) of Diagnostic Model

Summary

Nasopharyngeal cancer is common in China, Southeast Asia, and North Africa, and is usually
 associated with Epstein-Barr virus (EBV) infection. Using EBV specific antibodies or EBV DNA
 screening can increase the proportion of patients diagnosed with early nasopharyngeal
 carcinoma from approximately 20% to over 70%. However, the application of nasopharyngeal
 carcinoma screening in clinical practice is hindered by low positive predictive values, even
 in areas where the EB virus is prevalent in China, the positive predictive value is only
 4.8%. Therefore, there is an urgent need to identify new biomarkers or strategies with high
 sensitivity and positive predictive value for nasopharyngeal carcinoma screening.
 
 A study published in the Lancet sub journal 《eClinicalMedicine》 in 2023 showed that a tongue
 image model based on machine learning can serve as a stable diagnostic method for gastric
 cancer (AUC=0.89), and has been clinically validated in multiple centers. This study inspires
 researchers to introduce artificial intelligence machine learning technology into the
 diagnosis and treatment of nasopharyngeal cancer.
 
 In summary, this plan explores the establishment of tongue image machine learning models in
 nasopharyngeal carcinoma patients to help improve the positive predictive value of
 nasopharyngeal carcinoma screening.

ICD-10 classifications
Malignant neoplasm of nasopharynxMalignant neoplasm: Nasopharynx, unspecifiedMalignant neoplasm: Overlapping lesion of nasopharynxBenign neoplasm: NasopharynxMalignant neoplasm: Posterior wall of nasopharynx
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06129201
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06129201 through Pure Global AI's free database. This phase not specified trial is sponsored by Fifth Affiliated Hospital, Sun Yat-Sen University and is currently Not yet recruiting. The study focuses on Nasopharyngeal Carcinoma. Target enrollment is 5000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.